Instale la herramienta precio del oro!

Oro histórico precio de la plata

2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1989
1988
1987
1986
1985
1984
1983
1982
1981
1980
1979
1978
1977
1976
1975
1974
1973
1972
1971
1970
1969
1968



 1979/07/29
USD / Onza
Gold
Silver




1979 - 07
SMTWTFS
1234567
891011121314
15161718192021
22232425262728
293031 


Gold Oro histórico cuadro y el gráfico de precios

360 días gráfico ,
1 Ounce Gold=? USD
Gold Oro histórico cuadro y el gráfico de precios


Silver Tabla de Precios Históricos de plata y el gráfico

360 días gráfico ,
1 Ounce Silver=? USD
Silver Tabla de Precios Históricos de plata y el gráfico











Noticias de oro:
  • Fintepla: Uses, Instructions, Side Effects, Warnings - Drugs. com
    Fintepla is a prescription medicine used to treat the seizures associated with Dravet syndrome and Lennox-Gastaut syndrome in patients 2 years of age and older Fintepla is a federally controlled substance (C-IV) because it contains fenfluramine Keep this medicine in a safe place to prevent misuse and abuse, and to protect it from theft
  • FINTEPLA® (fenfluramine) | Official Patient Website
    FINTEPLA is a prescription medicine used to treat seizures associated with Dravet syndrome and Lennox-Gastaut syndrome in patients 2 years of age and older It is not known if FINTEPLA is safe and effective in children less than 2 years of age
  • Homepage | Fintepla HCP
    Anyone considering prescribing FINTEPLA or any other AED must balance the risk of suicidal thoughts or behaviors with the risks of untreated illness Epilepsy and many other illnesses for which AEDs are prescribed are themselves associated with morbidity and mortality and an increased risk of suicidal thoughts and behaviors
  • Fenfluramine - Epilepsy Foundation
    Fenfluramine is the generic name (non-brand name) of a seizure medicine with the brand name Fintepla® from Zogenix Fenfluramine is approved for use: In the US, the FDA has approved fenfluramine to treat seizures associated with Dravet syndrome and Lennox-Gastaut syndrome in persons 2 years of age and older Liquid: 2 2 mg mL
  • Fintepla (fenfluramine): Uses, Side Effects, Dosage Reviews
    Fintepla (fenfluramine) is an antiepileptic (antiseizure) medication that's used for people ages 2 years and older This medication is only meant for those with seizures caused by Dravet syndrome or Lennox-Gastaut syndrome, not other seizure conditions
  • U. S. FDA Approves FINTEPLA[®] (fenfluramine) Oral Solution . . .
    FINTEPLA ® (fenfluramine) oral solution is a prescription medication approved by the FDA and authorized by the EU Commission, and under regulatory review with the PMDA (Japan), for the treatment of seizures associated with Dravet syndrome in patients two years of age and older 8,12 A Type II Variation Application has also been submitted to
  • Fintepla: Side effects, cost, dosage, uses, interactions, and . . .
    Fintepla is prescribed to treat seizures caused by certain types of epilepsy in children ages 2 years and older The dosage of Fintepla for children is the same as for adults For details, see
  • Fintepla: Uses, Side Effects, Dosage, Interactions, and More
    Fintepla (fenfluramine) is a prescription drug that’s used to treat seizures from certain epilepsy conditions Fintepla comes as an oral solution Fintepla is used in adults and certain children
  • Fintepla (fenfluramine) - Uses, Side Effects, and More
    Fintepla (fenfluramine) is commonly used to treat certain types of seizures in people with epilepsy Fintepla may also be used for other conditions as determined by your health care provider
  • FDA Approves New Therapy for Dravet Syndrome | FDA
    FDA approves Fintepla (fenfluramine), a Schedule IV controlled substance, for the treatment of seizures associated with Dravet syndrome in patients age 2 and older Dravet syndrome is a life





precio del oro, comprar oro, vender oro ©2005-2009
|En tiempo real Tipo de Cambio |disclaimer